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ear  Editor,
WHO  estimated  that  people  with  diabetes  (DM)
ave 2—3  times  increased  risk  of  tuberculosis  (TB)
ompared  to  people  without  DM  [1]. Worldwide,
0% of  TB  cases  are  linked  to  DM  [2].  Studies
ave shown  that  DM  not  only  increases  the  risk
f active  TB  but  also  puts  co-affected  person  at
ncreased  risk  of  poor  outcomes  [3]. Therefore,  pre-
entive treatment  is an  important  intervention  to
educe the  burden  of  TB.  An  effective  host  immune
ystem is  a  vital  factor  for  control  of  the  Mycobac-
erium tuberculosis  (Mtb)  growth.  Host-targeted
herapeutic strategy  decreases  microbial  resistance
ore  than  direct  pathogen  targeted  conventional
nti-TB drugs  [4].
Recent  estimates  show  that  around  15%  of
ulmonary tuberculosis  (TB)  cases  have  been
ttributed diabetes  (DM)  in  India  [5].  A  study  of
utrition  and  DM  changes  in  India  also  suggests  that
ncreased  DM  prevalence  contributed  to  an  increase
n the  total  number  of  TB  cases  in  the  country,  which
utnumbers  the  rate  of  population  growth  in  a given
ime period.  A  study  from  Kerala  demonstrated  that
rug sensitive  TB  patients  with  DM  are  less  likely
o respond  to  ﬁrst  line  TB  treatment  than  those
ithout DM  [6].  Therefore  patients  who  suffer  from
oth DM  and  TB  constitute  a  special  population  with
reater vulnerability.
Singhal  et  al.  found  that  the  AMPK-activating
ntidiabetic  drug  metformin  inhibits  the  intracellu-
ar growth  of  Mtb,  restricts  disease  immunopathol-
gy and  enhances  the  efﬁcacy  of  conventional
nti-TB drugs  [3]. Their  data  suggest  that  both  pro-
ective immunity  and  pathological  immunity  canPlease  cite  this  article  in  press  as:  Sonal  Sekhar  M,  et  al.  
diabetic  patients.  J  Infect  Public  Health  (2016),  http://dx.d
e independently  modulated  with  beneﬁcial  effects
uring  Mtb  infection  because  metformin  enhances
tb-speciﬁc host  immunity,  reduces  inﬂammation,
ttp://dx.doi.org/10.1016/j.jiph.2016.05.004
876-0341/© 2016 King Saud Bin Abdulaziz University for Health Scieromotes  disease  resolution,  and  improve  TB  treat-
ent outcomes.
We hypothesise  that  AMPK-activating  agent  met-
ormin can  boost  host  immunity,  thereby  protect
M patients  from  TB  infection.  Since  metformin
s already  being  used  extensively  in the  clinical
ractice for  T2DM,  a  large  scale  intervention,  based
n well-designed  trials  will  help  us  to  demonstrate
reventive value  of  metformin  in  TB,  particularly
mong diabetics.
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ll  the  authors  declare  that  there  are  no  conﬂicts
f interest  involved.
eferences
1] World Health Organization. Global tuberculosis report; 2014.
2] Lin Y, Li L, Mi F, Du J, Dong Y, Li Z, et al. Screening patients
with diabetes mellitus for tuberculosis in China. Trop Med Int
Health 2012;17(10):1302—8.
3] Jeon CY, Harries AD, Baker MA, Hart JE, Kapur A, Lön-
nroth K, et al. Bi-directional screening for tuberculosis
and diabetes: a systematic review. Trop Med Int Health
2010;15(11):1300—14.
4] Singhal A, Jie L, Kumar P, Hong GS, Leow MK, Paleja B, et al.
Metformin as adjunct antituberculosis therapy. Sci Transl Med
2014;6(263):263ra159.
5] Balakrishnan S, Vijayan S, Nair S, Subramoniapillai J,
Mrithyunjayan S, Wilson N, et al. High diabetes preva-
lence among tuberculosis cases in Kerala, India. PLoS ONE
2012;7(10):e46502.
6] Balakrishnan S, Prema J, Sunil Kumar M, Nair S, Dewan PK.
Diabetes mellitus increases risk of failing treatment in drug
susceptible TB patients. Int J Tuberc Lung Dis 2011;3:S348.
Miraj  Sonal  Sekhar ∗
Mazhuvancherry  Kesavan  UnnikrishnanProtective  effect  of  metformin  against  tuberculosis  in
oi.org/10.1016/j.jiph.2016.05.004
Department of  Pharmacy  Practice,  Manipal
College  of  Pharmaceutical  Sciences,  Manipal
University,  Manipal,  India
nces. Published by Elsevier Limited. All rights reserved.
 INJIPH-585; No. of Pages 2 ARTICLE
2  
Navya  Vyas
Department  of  Public  Health,  Manipal  University,
Manipal,  IndiaPlease  cite  this  article  in  press  as:  Sonal  Sekhar  M,  et  al.  
diabetic  patients.  J  Infect  Public  Health  (2016),  http://dx.d
∗Corresponding  author  at:  Department  of
Pharmacy  Practice,  Manipal  College  of
Pharmaceutical  Sciences,  Manipal  University,
Available  online  at  www
ScienceD PRESS
Letter  to  the  Editor
Manipal  576104,  India.  Tel.:  +91  8202922482;
fax:  +91  8202571998;  mobile:  +91  7411338846.
E-mail addresses:  sonalsekhar@gmail.com,Protective  effect  of  metformin  against  tuberculosis  in
oi.org/10.1016/j.jiph.2016.05.004
sonal.sekhar@manipal.edu  (M.  Sonal  Sekhar).
1  May  2016
.sciencedirect.com
irect
